Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19

Vanessa Sacco, Barbara Rauch, Christina Gar, Stefanie Haschka, Anne L. Potzel, Stefanie Kern-Matschilles, Friederike Banning, Irina Benz, Mandy Meisel, Jochen Seissler, View ORCID ProfileAndreas Lechner
doi: https://doi.org/10.1101/2020.07.23.20161042
Vanessa Sacco
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Rauch
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Gar
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefanie Haschka
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne L. Potzel
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefanie Kern-Matschilles
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friederike Banning
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irina Benz
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mandy Meisel
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jochen Seissler
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Lechner
1Diabetes Research Group, Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany
2Clinical Cooperation Group Type 2 Diabetes, Helmholtz Zentrum München, Neuherberg, Germany
3German Center for Diabetes Research (DZD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andreas Lechner
  • For correspondence: andreas.lechner@med.uni-muenchen.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective The occurrence of pneumonia separates severe cases of COVID-19 from the majority of cases with mild disease. However, the factors determining whether or not pneumonia develops remain to be fully uncovered. We therefore explored the associations of several lifestyle factors with signs of pneumonia in COVID-19.

Methods Between May and July 2020, we conducted an online survey of 201 adults in Germany who had recently gone through COVID-19, predominantly as outpatients. Of these, 165 had a PCR-based diagnosis and 36 had a retrospective diagnosis by antibody testing. The survey covered demographic information, eight lifestyle factors, comorbidities and medication use. We defined the main outcome as the presence vs. the absence of signs of pneumonia, represented by dyspnea, the requirement for oxygen therapy or intubation.

Results Signs of pneumonia occurred in 39 of the 165 individuals with a PCR-based diagnosis of COVID-19 (23.6%). Among the lifestyle factors examined, only overweight/obesity associated with signs of pneumonia (odds ratio 2.68 (1.29 - 5.59) p=0.008). The observed association remained significant after multivariate adjustment, with BMI as a metric variable, and also after including the antibody-positive individuals into the analysis.

Conclusions This exploratory study finds an association of overweight/obesity with signs of pneumonia in COVID-19. This finding suggests that a signal proportional to body fat mass, such as the hormone leptin, impairs the body’s ability to clear SARS-CoV-2 before pneumonia develops. This hypothesis concurs with previous work and should be investigated further to possibly reduce the proportion of severe cases of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by LMU Klinikum, Helmholtz Zentrum Munchen, and the German Center for Diabetes Research.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

ethics board, LMU medical faculty, Munich, Germany

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Additional details added to methods section; some language corrections

Data Availability

Data from this study are available from the corresponding author upon reasonable request and within the framework of European data protection laws.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19
Vanessa Sacco, Barbara Rauch, Christina Gar, Stefanie Haschka, Anne L. Potzel, Stefanie Kern-Matschilles, Friederike Banning, Irina Benz, Mandy Meisel, Jochen Seissler, Andreas Lechner
medRxiv 2020.07.23.20161042; doi: https://doi.org/10.1101/2020.07.23.20161042
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19
Vanessa Sacco, Barbara Rauch, Christina Gar, Stefanie Haschka, Anne L. Potzel, Stefanie Kern-Matschilles, Friederike Banning, Irina Benz, Mandy Meisel, Jochen Seissler, Andreas Lechner
medRxiv 2020.07.23.20161042; doi: https://doi.org/10.1101/2020.07.23.20161042

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5214)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (749)
  • Geriatric Medicine (76)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (222)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5814)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (853)
  • Public and Global Health (1992)
  • Radiology and Imaging (343)
  • Rehabilitation Medicine and Physical Therapy (156)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)